Citation Impact

Citing Papers

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Challenges in the Treatment of Chronic Wounds
2015 Standout
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
1999 Standout
Human bone marrow‐derived cells: An attractive source to populate dermal substitutes
2007
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
Molecular Determinants of Regulatory T Cell Development: The Essential Roles of Epigenetic Changes
2013 StandoutNobel
Genetics of autoimmune diseases — disorders of immune homeostasis
2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Treatment of relapsing polychondritis with rituximab: A retrospective study of nine patients
2009
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Epistasis and immunity: the role of genetic interactions in autoimmune diseases
2012
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
2013
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Towards improved criteria for the antiphospholipid syndrome
1998

Works of C. Francès being referenced

Familial Lupus Erythematosus
2001
Presence of gelatinase A and etalloelastase type protease at the plasma membrane of human skin fibroblasts. Influence of cytokines and growth factors on cell‐associated metalloendopeptidase levels
1994
Dermatologic Manifestations of Relapsing Polychondritis
2001
Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus
1997
Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.
2003
Rankless by CCL
2026